ENANTA PHARMACEUTICALS, INC Stock Split Ratio
ENANTA PHARMACEUTICALS, INC (ENTA) reported Stock Split Ratio of 431.00% for the 1-month period ending 2013-03-01, per its 10-K filed 2013-12-18.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2015-12-11
- 2013-03-01: Stockholders' Equity Note, Stock Split, Conversion Ratio 431.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 431.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed 23.20%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed |
|---|---|---|---|
| 2013-03-01 | 431.00% 10-K · filed 2015-12-11 | 431.00% 10-K · filed 2013-12-18 | 23.20% 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |